Mammalian target of rapamycin inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late?
出版年份 2020 全文链接
标题
Mammalian target of rapamycin inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late?
作者
关键词
-
出版物
World Journal of Gastrointestinal Surgery
Volume 12, Issue 4, Pages 149-158
出版商
Baishideng Publishing Group Inc.
发表日期
2020-04-21
DOI
10.4240/wjgs.v12.i4.149
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm
- (2018) Kin Pan Au et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Sorafenib treatment in recurrent hepatocellular carcinoma post liver transplantation.
- (2017) Nazanin Fallah-Rad et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
- (2017) Elena Fernandez-Sevilla et al. LIVER TRANSPLANTATION
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus
- (2015) Lutz Fischer et al. TRANSPLANTATION
- Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series
- (2014) G. Sapisochin et al. ANNALS OF SURGICAL ONCOLOGY
- Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma
- (2013) Manuel Rodríguez-Perálvarez et al. JOURNAL OF HEPATOLOGY
- Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma
- (2012) K. V. Menon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis
- (2011) Wenhua Liang et al. LIVER TRANSPLANTATION
- Influence of Immunosuppressive Drugs on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Gap Between Basic Science and Clinical Evidence
- (2011) Andreas A. Schnitzbauer et al. TRANSPLANTATION
- A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
- (2010) Andreas A Schnitzbauer et al. BMC CANCER
- Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: Clinical patterns and outcome variables
- (2009) A. Kornberg et al. EJSO
- Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma
- (2009) Christian Toso et al. HEPATOLOGY
- Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation
- (2009) Srinath Chinnakotla et al. LIVER TRANSPLANTATION
- Recurrence of Hepatocellular Carcinoma Following Liver Transplantation
- (2008) Michael A. Zimmerman ARCHIVES OF SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now